This PDF is the current document as it appeared on Public Inspection on 01/23/2015 at 08:45 am.
Notice of registration.
S & B Pharma, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants S & B Pharma, Inc. registration as a manufacturer of those controlled substances.End Preamble Start Supplemental Information
By notice dated July 1, 2014, and published in the Federal Register on July 8, 2014, 79 FR 38564, S & B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice.
The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of S & B Pharma, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed:
|Gamma Hydroxybutyric Acid (2010)||I|
|4-Anilino-N-phenethyl-4-piperidine (ANPP) (8333)||II|
The company plans to manufacture the listed controlled substances in bulk for use in product development and for commercial sales to its customers.Start Signature
Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01287 Filed 1-23-15; 8:45 am]
BILLING CODE P